Rebecca J. Leeman-Neill, Ph.D.
Affiliations: | 2008 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Oncology, Pharmacology, PathologyGoogle:
"Rebecca Leeman-Neill"Parents
Sign in to add mentor| Jennifer R. Grandis | grad student | 2008 | University of Pittsburgh | |
| (Prevention and treatment of head and neck cancer with natural compound inhibitors of STAT3.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Leeman-Neill RJ, Bhagat G. (2018) BCL6 as a therapeutic target for lymphoma. Expert Opinion On Therapeutic Targets. 1-10 |
| Bogdanova TI, Zurnadzhy LY, Nikiforov YE, et al. (2015) Histopathological features of papillary thyroid carcinomas detected during four screening examinations of a Ukrainian-American cohort. British Journal of Cancer. 113: 1556-64 |
| Gibson SE, Leeman-Neill RJ, Jain S, et al. (2015) Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene. British Journal of Haematology |
| Leeman-Neill RJ, Johnson DE, Swerdlow SH. (2015) The Herbicide Isoproturon Induces Activation-Induced Cytidine Deaminase Expression in Germinal Center B Cells Blood. 126: 4816-4816 |
| Leeman-Neill RJ, Brenner AV, Little MP, et al. (2013) RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer. 119: 1792-9 |
| Leeman-Neill RJ, Brenner AJ, Little MP, et al. (2013) Abstract 3599: Prevalance and spectrum of chromosomal rearrangements in post-Chernobyl thyroid cancer. Cancer Research. 73: 3599-3599 |
| Leeman-Neill RJ, Seethala RR, Singh SV, et al. (2011) Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma. Cancer Prevention Research (Philadelphia, Pa.). 4: 230-7 |
| Wheeler SE, Suzuki S, Thomas SM, et al. (2010) Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation. Oncogene. 29: 5135-45 |
| Leeman-Neill RJ, Cai Q, Joyce SC, et al. (2010) Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2571-9 |
| Leeman-Neill RJ, Wheeler SE, Singh SV, et al. (2009) Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3. Carcinogenesis. 30: 1848-56 |